Journal article
Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial
American journal of respiratory and critical care medicine, Vol.176(1), pp.42-48
07/01/2007
DOI: 10.1164/rccm.200612-1797OC
PMCID: PMC2049064
PMID: 17363767
Abstract
Rationale
: Computed tomography (CT) scanning of the lung may reduce phenotypic heterogeneity in defining subjects with chronic obstructive pulmonary disease (COPD), and allow identification of genetic determinants of emphysema severity and distribution.
Objectives
: We sought to identify genes associated with CT scan distribution of emphysema in individuals without α
1
-antitrypsin deficiency but with severe COPD.
Methods
: We evaluated baseline CT densitometry phenotypes in 282 individuals with emphysema enrolled in the Genetics Ancillary Study of the National Emphysema Treatment Trial, and used regression models to identify genetic variants associated with emphysema distribution.
Measurements and Main Results
: Emphysema distribution was assessed by two methods—assessment by radiologists and by computerized density mask quantitation, using a threshold of −950 Hounsfield units. A total of 77 polymorphisms in 20 candidate genes were analyzed for association with distribution of emphysema.
GSTP1
,
EPHX1
, and
MMP1
polymorphisms were associated with the densitometric, apical-predominant distribution of emphysema (p value range = 0.001–0.050). When an apical-predominant phenotype was defined by the radiologist scoring method,
GSTP1
and
EPHX1
single-nucleotide polymorphisms were found to be significantly associated. In a case–control analysis of COPD susceptibility limited to cases with densitometric upper-lobe–predominant cases, the
EPHX1
His139Arg single-nucleotide polymorphism was associated with COPD (p = 0.005).
Conclusions
: Apical and basal emphysematous destruction appears to be influenced by different genes. Polymorphisms in the xenobiotic enzymes,
GSTP1
and
EPHX1
, are associated with apical-predominant emphysema. Altered detoxification of cigarette smoke metabolites may contribute to emphysema distribution, and these findings may lead to further insight into genetic determinants of emphysema.
Details
- Title: Subtitle
- Genetic Determinants of Emphysema Distribution in the National Emphysema Treatment Trial
- Creators
- Dawn L DeMeo - Channing Laboratory andCraig P Hersh - Channing Laboratory andEric A Hoffman - Channing Laboratory andAugusto A Litonjua - Channing Laboratory andRoss Lazarus - Channing Laboratory andDavid Sparrow - Channing Laboratory andJoshua O Benditt - Channing Laboratory andGerard Criner - Channing Laboratory andBarry Make - Channing Laboratory andFernando J Martinez - Channing Laboratory andPaul D Scanlon - Channing Laboratory andFrank C Sciurba - Channing Laboratory andJames P Utz - Channing Laboratory andJohn J Reilly - Channing Laboratory andEdwin K Silverman - Channing Laboratory and
- Resource Type
- Journal article
- Publication Details
- American journal of respiratory and critical care medicine, Vol.176(1), pp.42-48
- DOI
- 10.1164/rccm.200612-1797OC
- PMID
- 17363767
- PMCID
- PMC2049064
- NLM abbreviation
- Am J Respir Crit Care Med
- ISSN
- 1073-449X
- eISSN
- 1535-4970
- Publisher
- American Thoracic Society
- Language
- English
- Date published
- 07/01/2007
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Internal Medicine
- Record Identifier
- 9984051887802771
Metrics
12 Record Views